 |
| |
 | | Follow-up | |
 | 
Evaluate patients in 1 to 2 weeks after initial discharge, looking for delayed neurologic sequelae.  |
- Instruct patients to see their primary care providers if they develop recurrent or new neuropsychiatric deficits within 1 month of initial exposure.
- At the return visit perform a full neurologic exam to determine if any new deficits exist.
- If new or recurrent deficits exist, ask the patient about ongoing CO exposure and retest HbCO.
- If significant neuropsychiatric deficits remain during reexamination, use brain CT scanning to prognosticate future recovery.
- Recognize that treatment of delayed neuropsychiatric sequelae is supportive and does not have specific drug or non-drug therapy.
- See table Elements of Follow-up for CO Poisoning.
| Background
|  | | FAQs |
|
| Carlos Scheinkestel, MD, editorial consultant, has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Jeffrey T. Chapman, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. |
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|